Immune modulation in Pompe disease treated with enzyme replacement therapy
2012
, many challenges remain. The development of an immune response with resultant loss of therapeu-tic efficacy of ERT remains a significant issue in Pompe disease, most notably in the infantile form. Similar obstacles have been faced in other conditions treated with therapeutic proteins, including hemo-philia, diabetes and multiple sclerosis, as well as lysosomal storage diseases like Fabry disease, Gaucher disease and the mucopolysaccharidoses
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
19
References
21
Citations
NaN
KQI